Profesora Skrides Sirds klinika SIA
- Address
- Krisjana Valdemara Iela 62, LV-1013 Riga, Latvia
Cardiovascular Research
The site focuses on Cardiovascular Diseases, studying conditions such as atrial fibrillation, heart failure with preserved ejection fraction, type 2 diabetes and hypertension. Trials aim to test new drug combinations and improve outcomes for patients with established cardiovascular risk.
- Combination therapy with vicadrostat and empagliflozin
- Maintenance of sinus rhythm using etacizin
- Inflammation‑targeted treatment with ziltivekimab
Profesora Skrides Sirds klinika SIA is expanding its cardiovascular portfolio to bring innovative options to the Riga community.
Respiratory Research
Investigations at the centre also cover Respiratory Tract Diseases, with a particular emphasis on moderate‑to‑severe chronic obstructive pulmonary disease. The goal is to evaluate therapies that can lessen exacerbations and improve daily breathing function.
- COPD exacerbation reduction with verekitug
- Long‑term management strategies for chronic obstructive pulmonary disease
The clinic’s respiratory program seeks to bring better symptom control and quality of life to patients across Latvia.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 80 other sites in Latvia
Therapeutic Area Benchmark — Latvia
Select a therapeutic area to compare against other sites in Latvia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Latvia
Market Share
Country: Latvia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Profesora Skrides Sirds klinika SIA
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Open-Label Trial Comparing Ethacizine and Propafenone Hydrochloride for Sinus Rhythm Maintenance in Atrial Fibrillation Patients | Olpha AS | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 1 | Unknown | 2025-10-15 | 2025-10-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.